Dow Up 0.08% Nasdaq Down 0.30%

TrovaGene, Inc. (TROV)

-NasdaqCM
5.09 Down 0.20(3.78%) 4:00PM EDT
Prev Close:5.29
Open:5.27
Bid:4.93 x 100
Ask:5.50 x 2000
1y Target Est:9.00
Beta:0.09
Next Earnings Date:N/A
Day's Range:5.00 - 5.46
52wk Range:2.97 - 8.50
Volume:148,858
Avg Vol (3m):154,552
Market Cap:96.21M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):388.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback